DUBLIN, Jan. 6, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it will host an Investor Meeting on January 31, 2014 in New York. The meeting will begin at 8:00 a.m. EST and will be webcast simultaneously.
The meeting will be hosted by Actavis' executive leadership team and will provide an overview of executional results in 2013, initiatives to drive long-term growth and an in-depth look at the company following the acquisition of Warner Chilcott plc last year, including the Company's latest financial forecast. A question-and-answer session will follow the formal presentations.
In-person attendance at the meeting is by invitation only. The webcast will be available live to investors and the media on Actavis' Web site or at the following link: http://www.videonewswire.com/event.asp?id=97019.
A replay of the webcast will be available approximately two hours following the completion of the event on the Company's Web site.
About Actavis
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Dublin, Ireland and U.S. administrative headquarters in Parsippany, New Jersey, USA.
Actavis markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries, and operates a global branded specialty pharmaceutical business focused in the Women's Health, Urology, Gastroenterology and Dermatology therapeutic categories. Actavis also has a portfolio of five biosimilar products in development in Women's Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.
For press release and other company information, visit Actavis' Web site at http://www.actavis.com.
CONTACTS: |
Investors: |
Lisa DeFrancesco |
|
(862) 261-7152 |
|
Media: |
|
Charlie Mayr |
|
(862) 261-8030 |
|
David Belian |
|
(862) 261-8141 |
(Logo: http://photos.prnewswire.com/prnh/20130124/NY47381LOGO )
SOURCE Actavis plc
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article